Transcriptional control of regulatory T cell development and function

Trends in Immunology

Volumn 34, Issue 11, 2013, Pages 531-539

  Luo, Chong T ^a   Li, Ming O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cell signaling; Foxo1; Foxp3; Transcription factor

Indexed keywords

CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR7; DNA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT5 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR REL; TRANSFORMING GROWTH FACTOR BETA;

BINDING SITE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; HISTONE MODIFICATION; IPEX SYNDROME; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL SIGNALING; FOXO1; FOXP3; TRANSCRIPTION FACTOR;

ANIMALS; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC;

EID: 84886947397     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.08.003     Document Type: Review

References (114)

1. Sakaguchi S., et al. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
2. Josefowicz S.Z., et al. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012, 30:531-564.
3. Nishizuka Y. Thymus and reproduction: Sex-linked dysgnesia of the gonad after neonatal thymectomy in mice. Science 1969, 166:753-755.
4. Sakaguchi S., et al. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 1982, 156:1577-1586.
5. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 2009, 27:551-589.
6. Curotto de Lafaille M.A., Lafaille J.J. Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor?. Immunity 2009, 30:626-635.
7. Zheng Y., et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
8. Ohkura N., et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 2012, 37:785-799.
9. Olivares-Villagómez D., et al. Regulatory CD4+ T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 1998, 188:1883-1894.
10. Hori S., et al. Specificity requirements for selection and effector functions of CD25+ 4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8213-8218.
11. Jordan M.S., et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2001, 2:301-306.
12. Hsieh C-S., et al. Recognition of the peripheral self by naturally arising CD25+CD4+ T cell receptors. Immunity 2004, 21:267-277.
13. Hinterberger M., et al. Autonomous role of medullary thymic epithelial cells in central CD4+ T cell tolerance. Nat. Immunol. 2010, 11:512-519.
14. Ouyang W., et al. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010, 32:642-653.
15. Salomon B., et al. B7/CD28 costimulation is essential for the homeostasis of the CD4(+)CD25(+) immunoregulatory T cells that control autoimmune diabetes. Immunity 2000, 12:431-440.
16. Tai X., et al. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 2005, 6:152-162.
17. Verhagen J., et al. Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3306-3311.
18. Schmidt-Supprian M., et al. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4566-4571.
19. Gupta S., et al. Differential requirement of PKC-θ in the development and function of natural regulatory T cells. Mol. Immunol. 2008, 46:213-224.
20. Medoff B.D., et al. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 2009, 39:78-84.
21. Wan Y.Y., et al. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 2006, 7:851-858.
22. Barnes M.J., et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 2009, 7:e51.
23. Long M., et al. Nuclear factor-κB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 2009, 31:921-931.
24. Ruan Q., et al. Development of Foxp3+ regulatory T cells is driven by the c-Rel enhanceosome. Immunity 2009, 31:932-940.
25. Isomura I., et al. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 2009, 206:3001-3014.
26. Oh-hora M., et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat. Immunol. 2008, 9:432-443.
27. Oh-hora M., et al. Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. Immunity 2013, 38:881-895.
28. Mantel P-Y., et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 2006, 176:3593-3602.
29. Tone Y., et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 2008, 9:194-202.
30. Vaeth M., et al. Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:16258-16263.
31. Bopp T. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. J. Exp. Med. 2005, 201:181-187.
32. Canté-Barrett K., et al. Selective role of NFATc3 in positive selection of thymocytes. J. Immunol. 2007, 179:103-110.
33. Kim H.P., Leonard W.J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 2007, 204:1543-1551.
34. Polansky J.K., et al. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 2008, 38:1654-1663.
35. Moran A.E., et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 2011, 208:1279-1289.
36. Sekiya T., et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat. Immunol. 2013, 14:230-237.
37. Sekiya T., et al. The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat. Commun. 2011, 2:269.
38. Fassett M.S., et al. Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3891-3896.
39. Burchill M.A., et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 2008, 28:112-121.
40. Lio C-W.J., Hsieh C-S. A two-step process for thymic regulatory T cell development. Immunity 2008, 28:100-111.
41. Fontenot J.D., et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 2005, 6:1142-1151.
42. Vang K.B., et al. IL-2,-7, and-15, but not thymic stromal lymphopoeitin, redundantly govern CD4+ Foxp3+ regulatory T cell development. J. Immunol. 2008, 181:3285-3290.
43. Yao Z., et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 2007, 109:4368-4375.
44. Burchill M.A., et al. IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 2007, 178:280-290.
45. Patton D.T., et al. Cutting edge: The phosphoinositide 3-kinase p110 delta is critical for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J. Immunol. 2006, 177:6598-6602.
46. Liu G., et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 2009, 10:769-777.
47. Haxhinasto S., et al. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 2008, 205:565-574.
48. Ouyang W., et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 2010, 11:618-627.
49. Kerdiles Y.M., et al. Foxo transcription factors control regulatory T cell development and function. Immunity 2010, 33:890-904.
50. Harada Y., et al. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 2010, 207:1381-1391.
51. Ouyang W., Li M.O. Foxo: in command of T lymphocyte homeostasis and tolerance. Trends Immunol. 2011, 32:26-33.
52. Singer A., et al. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 2008, 8:788-801.
53. Josefowicz S.Z., et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012, 482:395-399.
54. Samstein R.M., et al. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012, 150:29-38.
55. Kretschmer K., et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 2005, 6:1219-1227.
56. Gottschalk R.A., et al. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 2010, 207:1701-1711.
57. Lathrop S.K., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478:250-254.
58. Cebula A., et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013, 497:258-262.
59. Mucida D. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 2005, 115:1923-1933.
60. Curotto de Lafaille M.A., et al. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008, 29:114-126.
61. Verginis P., et al. Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3479-3484.
62. Daniel C., et al. Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J. Exp. Med. 2011, 208:1501-1510.
63. Xu L., et al. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 2010, 33:313-325.
64. Benson M.J., et al. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 2007, 204:1765-1774.
65. Zheng S.G., et al. TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells. J. Immunol. 2006, 176:3321-3329.
66. Sauer S. T cell receptor signaling controls Foxp3 expression via PI3K, Akt and mTOR. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7797-7802.
67. Delgoffe G.M., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009, 30:832-844.
68. Schlenner S.M., et al. Smad3 binding to the Foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J. Exp. Med. 2012, 209:1529-1535.
69. Davidson T.S., et al. Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 2007, 178:4022-4026.
70. Laurence A., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
71. Sun C.M., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
72. Mucida D., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
73. Hill J.A., et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 2008, 29:758-770.
74. Kim J.M., et al. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 2006, 8:191-197.
75. Lahl K., et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007, 204:57-63.
76. Shevach E.M. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
77. Khattri R., et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 2003, 4:337-342.
78. Chatila T.A., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000, 106:R75-R81.
79. Bennett C.L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
80. Wildin R.S., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
81. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 2007, 8:277-284.
82. Gavin M.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
83. Lin W., et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 2007, 8:359-368.
84. Hill J.A., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
85. Fu W., et al. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nat. Immunol. 2012, 13:972-980.
86. Pan F., et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009, 325:1142-1146.
87. Zheng Y., et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 2009, 458:351-356.
88. Rudra D., et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 2012, 13:1010-1019.
89. Samstein R.M., et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 2012, 151:153-166.
90. Rudra D., et al. Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 2009, 10:1170-1177.
91. Kitoh A., et al. Indispensable role of the Runx1-Cbfβ transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 2009, 31:609-620.
92. Wu Y., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
93. Chang J.H., et al. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat. Immunol. 2012, 13:481-490.
94. Loizou L., et al. Foxp3 interacts with c-Rel to mediate NF-kappaB repression. PLoS ONE 2011, 6:e18670.
95. Camperio C., et al. Forkhead transcription factor FOXP3 upregulates CD25 expression through cooperation with RelA/NF-kappaB. PLoS ONE 2012, 7:e48303.
96. Ouyang W., et al. Novel Foxo1-dependent transcriptional programs control Treg cell function. Nature 2012, 491:554-559.
97. Rao Rajesh R., et al. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8+ T cell differentiation. Immunity 2012, 36:374-387.
98. Koch M.A., et al. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2. Immunity 2012, 37:501-510.
99. Kerdiles Y.M., et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 2009, 10:176-184.
100. Ouyang W., et al. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 2009, 30:358-371.
101. Förster R., et al. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 2008, 8:362-371.
102. Schneider M.A., et al. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J. Exp. Med. 2007, 204:735-745.
103. Kocks J.R., et al. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J. Exp. Med. 2007, 204:723-734.
104. Kurobe H., et al. CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. Immunity 2006, 24:165-177.
105. Davalos-Misslitz A., et al. Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur. J. Immunol. 2007, 37:613-622.
106. Delgoffe G.M., et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 2013, 10.1038/nature12428.
107. Strainic M.G., et al. Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells. Nat. Immunol. 2012, 14:162-171.
108. Kwan W.H., et al. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J. Exp. Med. 2013, 210:257-268.
109. Oldenhove G., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
110. Zhao J., et al. IFNgamma- and IL-10-expressing virus epitope-specific Foxp3+ T reg cells in the central nervous system during encephalomyelitis. J. Exp. Med. 2011, 208:1571-1577.
111. Dominguez-Villar M., et al. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 2011, 17:673-675.
112. McClymont S.A., et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 2011, 186:3918-3926.
113. Zeng H., et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 2013, 10.1038/nature12297.
114. Sharma Madhav D., et al. An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor Eos. Immunity 2013, 38:998-1012.